SecurAcath® Significantly Reduces Catheter-Related Infection Risk By Judy|2024-03-14T20:47:20+00:00June 24th, 2020|News|0 Comments Read More
Italian Vascular Access Group Recommends Use of SecurAcath on COVID-19 Patients By Judy|2020-04-14T13:53:36+00:00April 14th, 2020|News|0 Comments Read More
SecurAcath Study of Over 2000 Patients Shows Major Cost Savings Compared to Adhesives By Judy|2019-07-23T19:18:08+00:00July 16th, 2019|News|0 Comments Read More
Interrad Medical Announces Agreement with Vygon to Distribute SecurAcath in France By Judy|2018-12-04T16:31:51+00:00October 15th, 2018|News|0 Comments Read More
New Clinical Data Shows Decreased Catheter-Related Infection Risk with Use of SecurAcath By Judy|2018-12-04T16:31:31+00:00September 26th, 2018|News|0 Comments Read More
SecurAcath Selected for Fast-Track NHS Use Through New Innovation and Technology Payment Program By Judy|2018-12-04T16:35:46+00:00April 10th, 2018|News|0 Comments Read More
SecurAcath Receives NICE Recommendation: Highlights Massive Cost Savings from Improved Catheter Securement By Judy|2018-12-04T16:45:46+00:00June 5th, 2017|News|0 Comments Read More
SecurAcath is the Only Subcutaneous Engineered Stabilization Device that Meets the 2016 Infusion Therapy Standards of Practice By Judy|2018-12-04T16:44:50+00:00March 16th, 2016|News|0 Comments Read More